Results 131 to 140 of about 11,703 (213)

Retraction: Oncolytic virotherapy promotes radiosensitivity in soft tissue sarcoma by suppressing anti-apoptotic MCL1 expression. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

Case Report: Integration of intratumoral oncolytic adenovirus with total neoadjuvant therapy in metachronous locally advanced rectal cancer. [PDF]

Front Oncol
Chen X, Zhao Z, Chen Z, Li W, Sun H.
europepmc   +1 more source

The Role of Viral Dynamics and Infectivity in Models of Oncolytic Virotherapy for Tumours with Different Motility. [PDF]

Bull Math Biol
Morselli D, Frascoli F, Delitala ME.
europepmc   +1 more source

Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration. [PDF]

Cancer Immunol Res
Ludwig AL, McKay ZP, Carter GP, Katz MA, Howell G, Jain V, Arvai S, Dittmer DP, Bigner DD, Ashley DM, Shoaf ML, Desjardins A, Gregory SG, Brown MC, Gromeier M.   +14 more
europepmc   +1 more source

Oncolytic Herpes Simplex Virus for Glioblastoma: Molecular Engineering, Tumor Microenvironment Barriers, and Clinical Translation. [PDF]

Curr Issues Mol Biol
Liu J, Wang Y, Gao Z, Liu T, Xu A, Li W, Li M, Song X, Guo B, Wang H, Lv W, Zhang J.   +11 more
europepmc   +1 more source

Precision virotherapies: Coming soon

Oncotarget, 2018
Uusi-Kerttula, Hanni, Parker, Alan L.
openaire   +2 more sources

Leveraging the bacteria for enhanced cancer immunotherapy: from a perspective of synthetic biology. [PDF]

Cancer Biol Ther
Liu X, Zhang H, Du R, Liu Z, Ren Y, Yang X.   +5 more
europepmc   +1 more source

A Decade of Oncolytic Virotherapy in Pediatric Cancers: A Systematic Review of Safety, Immune Awakening, and Emerging Efficacy. [PDF]

Cureus
BinSharhan AS, AlAbdullah AM, Alabdullatif SF, Aboushark YY, Alateeq NM, Alhajjaj WA, Alrabea HO, Saeedi F.   +7 more
europepmc   +1 more source

CD73 blockade enhances antitumor efficacy of oHSV in solid tumors by increasing macrophage-mediated antigen presentation. [PDF]

J Immunother Cancer
Murphy SA, Li J, Sahu U, Swanner J, Lewis CT, Anchang B, Cui Y, Chiocca EA, Kaur B.   +8 more
europepmc   +1 more source

Cracking the shield: oncolytic viruses versus the tumor-immune fortress. [PDF]

Cancer Cell Int
El-Derby AM, Salem NT, Hesham N, Salem TZ.   +3 more
europepmc   +1 more source